98%
921
2 minutes
20
Purpose: Nontuberculous mycobacteria (NTM) infection is an important issue after lung transplantation. However, a large-scale epidemiological study on this issue in Korea is lacking. We aimed to evaluate the epidemiology of NTM infection after lung transplant surgery in Korea.
Methods: Between October 2012 and December 2018, we retrospectively evaluated lung transplant recipients in a referral hospital in South Korea. A total of 215 recipients were enrolled. The median age at transplantation was 56 years (range, 17-75), and 62% were men. Bronchoscopy was performed according to the surveillance protocol and clinical indications. A diagnosis of NTM infection was defined as a positive NTM culture from a bronchial washing, bronchoalveolar lavage sample, or two separate sputum samples. We determined NTM pulmonary disease (NTM-PD) according to the American Thoracic Society/Infectious Disease Society of America 2007 guidelines. The Kaplan-Meier method and log-rank test were used for conditional survival analysis in patients with follow-up of ≥12 months.
Results: Fourteen patients (6.5%) were diagnosed with NTM infection at a median of 11.8 months (range, 0.3-51.4) after transplantation. Nine patients (4.2%) were diagnosed with NTM-PD, and the incidence rate was 1980/100,000 person-years. Mycobacterium abscessus was the most common species causing NTM-PD (66%), followed by M. avium complex (33%). The presence of NTM infection did not influence all-cause mortality among those who underwent follow-up for ≥12 months (N = 133, log-rank P = 0.816).
Conclusion: The incidence of NTM-PD was considerably high among lung-transplant recipients. M. abscessus was the most common causative species of NTM-PD after lung transplantation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jmii.2020.08.021 | DOI Listing |
Int J Infect Dis
September 2025
Goethe-University Frankfurt, University Hospital, Department of Medicine no. 2, Infectious Diseases. Electronic address:
Objectives: Disseminated nontuberculous mycobacterial disease (dNTMd) remains a rare but serious complication in people living with HIV (PLWH). This study aimed to assess whether dNTMd independently contributes to delayed CD4-cell recovery following antiretroviral therapy (ART) initiation.
Methods: This retrospective 1:3 single center case-control study analyzed patient data from 2004 to 2023.
IJID Reg
September 2025
Department of Hygiene, Sapporo Medical University School of Medicine, Sapporo, Japan.
Objectives: Nontuberculous mycobacteria (NTM) are an increasing cause of extrapulmonary infections affecting skin and soft tissue. This study aimed to determine the involvement of NTM in persistent surgical site infections (SSIs) in Bangladesh.
Methods: Specimens of SSIs (wound swab, pus, sinus discharge) were collected from patients who attended a tertiary care hospital during a 6-month period in 2024.
BMC Infect Dis
August 2025
College of Medicine and Health sciences, Department of Medical Microbiology, Univeristy of Gondar, Gondar, Ethiopia.
Introduction: Nontuberculous mycobacteria (NTM) are environmental pathogens found in soil, water, and various environments, causing chronic pulmonary infections. They are resistant to chlorine and extreme temperatures but not typically transmissible. NTM infections are often misdiagnosed as tuberculosis (TB), especially in Ethiopia, where data on prevalence is scarce.
View Article and Find Full Text PDFFront Immunol
August 2025
Department of Laboratory Medicine, Hebei Medical University Third Hospital, Shijiazhuang, China.
Background: The complex (MABC), a multidrug-resistant environmental mycobacterium, rarely causes joint infections, which typically involve prosthetic joints. We describe the first case of native-knee infection linked to herbal steam therapy and osteoarthritis-a previously unreported scenario, accompanied by a literature review of 20 global MABC joint infection cases (2013-2024). Our findings present an alternative approach to the therapeutic guidelines for nontuberculous mycobacteria (NTM) infections, demonstrating successful clinical resolution in this single case using a short-course oral regimen.
View Article and Find Full Text PDFFront Cell Infect Microbiol
August 2025
Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Objective: This study aimed to establish a multiplex molecular point-of-care assay called incorporating an ultra-fast sample pre-treatment for direct identification of complex (MTBC) and 8 non-tuberculous Mycobacteria (NTM) commonly prioritized in clinical settings, and to evaluate its performance in 149 clinical confirmed mycobacterial-positive samples.
Methods: The study was divided into two stages: a pilot study to establish the methodology and a clinical validation study to evaluate its performance. In the pilot study, we established the and analyzed its performance regarding limits of detection, reproducibility, specificity and efficiency.